Menu
Enrolling by invitation NCT04150458

Fluorocholine PET/CT Basket Trial

Phase III Interventional Fluorocholine PET/CT

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: 18F-fluorocholine PET/CT..
Who it may be relevant to
Registry conditions: Fluorocholine PET/CT. Basic parameters: 18 years — 110 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Canada
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Performance of 18F-Fluorocholine Positron Emission Tomography With Computed Tomography in Patients With 18F-Fluorocholine-avid Lesions: A Basket Trial

Overview

This is a single-arm, open-label, phase III trial in up to 2000 patients with known or suspected benign or malignant tumors which are known or suspected to be 18F-fluorocholine-avid. Patients will receive regular standard clinical care. The only study-specific procedure will be the administration of 18F-fluorocholine followed by a PET/CT scan. Diagnostic accuracy of 18F-fluorocholine PET/CT will be captured versus a composite clinical, radiological and histopathological standard of truth at follow-up.

Interventions

  • Drug 18F-fluorocholine PET/CT.
    18F-fluorocholine positron emission tomography / computed tomography

Primary outcome measures

  • Diagnostic accuracy of Fluorocholine PET/CT [Time frame: 1 day]
Secondary outcome measures (1)
  • Incidence of treatment-emergent adverse events following Fluorocholine PET/CT [Time frame: 30 minutes]

Eligibility criteria

Inclusion criteria

  • Age 18 years or older
  • Under referring physician's care
  • Able to understand and provide written informed consent
  • Able to tolerate the physical/logistical requirements of a PET/CT scan including lying supine (or prone) for up to 30 minutes and tolerating intravenous cannulation for injection
  • Known or suspected benign or malignant tumor which is known or suspected to be 18F-fluorocholine-avid as per current medical literature

Exclusion criteria

  • Medically unstable (e.g. acute cardiac or respiratory distress or hypotensive)
  • Exceeding the safe weight limit of the PET/CT bed (usually approximately 400 lbs.) or cannot fit through the PET/CT bore (usually approximately 70 cm diameter)
  • Unmanageable claustrophobia

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Diagnostic

Study locations

Canada · 1 center
  • Jewish General Hospital — Montreal

Identifiers

NCT: NCT04150458 · FCH Basket

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗